Showing results (511-520 of 573) with videos related to
Sort By:
Pageof 58
JCO Precision Oncology|July 12, 2021
Comprehensive Clinical and Molecular Characterization of KRAS G12C-Mutant Colorectal CancerJason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.JCO Global Oncology|July 9, 2026
Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning AssistantTucker J Netherton, Ajay Aggarwal, Qusai Alakayleh, et al.European Urology|August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND TrialAlexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II TrialEthan B Ludmir, Alexander D Sherry, Bryan M Fellman, et al.Annals of Intensive Care|June 18, 2020
Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenationDavid Hong, Ki Hong Choi, Yang Hyun Cho, et al.Cancer|September 24, 2004
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaStephen G Swisher, Jeremy Erasmus, Mary Maish, et al.JACC. Cardiovascular Interventions|February 26, 2025
Microvascular Resistance Reserve and Prognosis After Heart TransplantationJunho Ha, Seung Hun Lee, Ki-Hong Choi, et al.Med (New York, N.Y.)|June 28, 2025
Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancersSteven H Lin, Vivek Subbiah, Evan N Cohen, et al.European Urology|March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate CancerBrian F Chapin, Marc Smaldone, Amado J Zurita, et al.JACC. Asia|November 18, 2024
Fractional Flow Reserve and Fractional Flow Reserve Gradient From CCTA for Predicting Future Coronary EventsDavid Hong, Neng Dai, Seung Hun Lee, et al.Pageof 58